According to a new study published through the University of Virginia School of Medicine, blood tests of coronavirus patients can also help identify the most serious diseases of the virus and those who prefer a fan.
Studies can also generate a new therapy to save you the fatal “cytokine storms,” a term for when cytokines, a protein produced through immune cells, cause an overreaction of the immune formula at severe COVID-1nine moments and save lives, according to a report through UVAToday, Virgina University’s news website.
“The immune response that we discovered to predict severe shortness of breath in COVID-19 is known in other pulmonary diseases to cause damage. So this could lead to a novel way to prevent respiratory failure in individuals infected with the new coronavirus, by inhibiting this immune cytokine,” Dr Bill Petri, a physician at the University’s Division of Infectious Diseases and International Health told UVAToday.
For lacheck titles, stick to our Google News channel online or through the app
“We plan to verify this in a COVID-1nine genus before a clinical trial,” he added.
Reseek revealed that the degrees of an explicit cytokine, IL-13, were applicable with a worse coronavirus result, regardless of other patient factors, such as sex, age or pre-existing physical condition problems.
Two other cytokines were also applicable with more serious effects, but were less favorable in predicting whether a patient would want a ventilator.
Finally, two other cytokines that are consistent with grades were discovered in patients with h8 blood pressure, which could be the reason why diabetes was known as a key threat in the worst coronavirus results.
Researchers used the knowledge of 57 coronavirus patients who were treated at the University of Virginia and preferred a ventilator, and then, by comparison, the blood effects with patients who did not prefer a ventilator.
Further studies have been conducted on the role that blood can play in the coronavirus pandemic.
In early June, research conducted by biotech testing company 23andMe suggested that a person’s blood type can dictate how likely they are to catch the coronavirus. People with O blood type better protected against the coronavirus, compared to other blood types, and are between 9 and 18 percent less likely to test positive for COVID-19.